Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Paclitaxel and Everolimus in TNBC
NCT00930930Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jun 2009
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Jun 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00930930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930930.